Publications scientifiques en 2012

Depuis le 30/04/2024

  1. Intervention multifactorielle sur le syndrome métabolique au cours d'une cure thermale ? Eugènie-les-bains (France).
    Gin H, Demeaux JL, Grelaud A, Grolleau A, Droz-Perroteau C, Robinson P, ... Moore N.
    Press Therm Climat. 2012
  2. Ethanol Extract of Abnormal Savda Munziq, a Herbal Preparation of Traditional Uighur Medicine, Inhibits Caco-2 Cells Proliferation via Cell Cycle Arrest and Apoptosis.
    Yusup A, Upur H, Umar A, Berke B, Moore N.
    Evid Based Complement Alternat Med. 2012
  3. Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?
    Daveluy A, Milpied B, Barbaud A, Lebrun-Vignes B, Gouraud A, Laroche ML, Ciobanu E, Bégaud B, Moore N, Miremont-Salamé G, Haramburu F, The French Pharmacovigilance Centres Network and The Toxidermia Group of the French Society of Dermatology.
    Eur J Clin Pharmacol. 2012
  4. Engagement in leisure activities and benzodiazepine use in a French community-dwelling elderly population.
    Bazin F, Noize P, Dartigues JF, Ritchie KA, Tavernier B, Moore N, ... Fourrier-Reglat A.
    Int J Geriatr Psychiatry. 2012
  5. Road traffic crashes and prescribed methadone and buprenorphine: a French registry-based case-control study.
    Corsenac P, Lagarde E, Gadegbeku B, Delorme B, Tricotel A, Castot A, Moore N, Philip P, Laumon B, Orriols L.
    Drug Alcohol Depend. 2012
  6. How innovative are pharmaceutical innovations?: the case of medicines financed through add-on payments outside of the French DRG-based hospital payment system.
    Gridchyna I, Aulois-Griot M, Maurain C, Bégaud B.
    Health Policy. 2012
  7. Implementation of an automated signal detection method in the French pharmacovigilance database: a feasibility study.
    Pizzoglio V, Ahmed I, Auriche P, Tuber-Bitter P, Haramburu F, Kreft-Jais C, Miremont-Salame G.
    Eur J Clin Pharmacol. 2012
  8. Hypersensitivity syndrome with olanzapine confirmed by patch tests. .
    Prevost P, Bedry R, Lacoste D, Ezzedine K, Haramburu F, Milpied B.
    Eur J Dermatol. 2012
  9. [Rare association between chronic lymphocytic leukemia and systemic lupus erythematosus].
    Dieval C, Herrador C, Guiboux AL, Haramburu F, Mercie P.
    Presse Med. 2012
  10. Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database.
    Blin P, Lassalle R, Dureau-Pournin C, Ambrosino B, Bernard MA, Abouelfath A, ... Moore N.
    Diabetologia. 2012
  11. Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers. .
    Tournier M, Bégaud B, Cougnard A, Auleley GR, Deligne J, Blum-Boisgard C, ... Verdoux H.
    Br J Clin Pharmacol. 2012
  12. Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study.
    Dumas de La Roque E, Savineau JP, Metivier AC, Billes MA, Kraemer JP, Doutreleau S, ... Dromer C.
    Ann Endocrinol (Paris). 2012
  13. Role of YKL-40 in bronchial smooth muscle remodeling in asthma.
    Bara I, Ozier A, Girodet PO, Carvalho G, Cattiaux J, Begueret H, ... Berger P.
    Am J Respir Crit Care Med. 2012
  14. Administrative complexities for a European observational study despite directives harmonising requirements.
    Gulmez SE, Lignot-Maleyran S, de Vries CS, Sturkenboom M, Micon S, Hamoud F, ... Moore N.
    Pharmacoepidemiol Drug Saf. 2012
  15. Use of health insurance claim patterns to identify patients using nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.
    Bernard MA, Benichou J, Blin P, Weill A, Bégaud B, Abouelfath A, ... Fourrier-Reglat A.
    Pharmacoepidemiol Drug Saf. 2012
  16. Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study. .
    Renard JP, Rouland JF, Bron A, Sellem E, Nordmann JP, Baudouin C, ... Delcourt C.
    Acta Ophthalmol. 2012
  17. Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors.
    Pariente A, Fourrier-Reglat A, Bazin F, Ducruet T, Dartigues JF, Dragomir A, ... Moride Y.
    Neurology. 2012
  18. Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study.
    Ahmed I, Thiessard F, Miremont-Salame G, Haramburu F, Kreft-Jais C, Bégaud B, Tubert-Bitter P.
    Drug Saf. 2012
  19. Preventive and curative effect of Trigonella foenum-graecum L. seeds in C57BL/6J models of type 2 diabetes induced by high-fat diet.
    Hamza N, Berke B, Cheze C, Le Garrec R, Umar A, Agli AN, ... Moore N.
    J Ethnopharmacol. 2012
  20. Factors associated with serious traffic crashes: a prospective study in southwest France.
    Blazejewski S, Girodet PO, Orriols L, Capelli A, Moore N.
    Arch Intern Med. 2012
  21. Prescription-drug-related risk in driving: comparing conventional and lasso shrinkage logistic regressions.
    Avalos M, Adroher ND, Lagarde E, Thiessard F, Grandvalet Y, Contrand B, Orriols L.
    Epidemiology. 2012
  22. Validity of chronic drug exposure presumed from repeated patient interviews varied according to drug class.
    Noize P, Bazin F, Pariente A, Dufouil C, Ancelin ML, Helmer C, ... Fourrier-Reglat A.
    J Clin Epidemiol. 2012
  23. Health and aging in elderly farmers: the AMI cohort.
    Peres K, Matharan F, Allard M, Amieva H, Baldi I, Barberger-Gateau P, ... Dartigues JF.
    BMC Public Health. 2012
  24. An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance. .
    Theophile H, Andre M, Arimone Y, Haramburu F, Miremont-Salame G, Bégaud B.
    J Clin Epidemiol. 2012
  25. Bioavailability of glycitein relatively to other soy isoflavones in healthy young Caucasian men. .
    Shinkaruk S, Durand M, Lamothe V, Carpaye A, Martinet A, Chantre P, ... Bennetau-Pelissero C.
    Food Chem. 2012
  26. Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.
    Pariente A, Avillach P, Salvo F, Thiessard F, Miremont-Salame G, Fourrier-Reglat A, ... Moore N.
    Drug Saf. 2012
  27. Risk of injurious road traffic crash after prescription of antidepressants.
    Orriols L, Queinec R, Philip P, Gadegbeku B, Delorme B, Moore N, ... Lagarde E.
    J Clin Psychiatry. 2012
  28. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
    Droz-Perroteau C, Marchal C, Dureau-Pournin C, Lassalle R, Jove J, Robinson P, ... Fourrier-Reglat A.
    Pharmacoepidemiol Drug Saf. 2012
  29. A review of the pharmacokinetic profile of transmucosal fentanyl formulations.
    Moore N, Darwish M, Amores X, Schneid H.
    Curr Med Res Opin. 2012
  30. Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial. .
    Prey S, Ezzedine K, Doussau A, Grandoulier AS, Barcat D, Chatelus E, ... Taieb A.
    Br J Dermatol. 2012
  31. Benzodiazepine use and risk of dementia: prospective population based study.
    Billioti de Gage S, Bégaud B, Bazin F, Verdoux H, Dartigues JF, Peres K, ... Pariente A.
    BMJ. 2012
  32. Identification of abuse and dependence cases through a hospital database.
    Daveluy A, Miremont-Salame G, Kostrzewa A, Couret A, Lacoin L, Lecomte C, ... Haramburu F.
    Pharmacoepidemiol Drug Saf. 2012
  33. Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory.
    Bouchet S, Titier K, Moore N, Lassalle R, Ambrosino B, Poulette S, ... Molimard M.
    Fundam Clin Pharmacol. 2012
  34. In Vivo Micro-CT Assessment of Airway Remodeling in a Flexible OVA-Sensitized Murine Model of Asthma.
    Lederlin M, Ozier A, Dournes G, Ousova O, Girodet PO, Begueret H, ... Berger P.
    PLoS One. 2012
  35. Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy.
    Mustjoki S, Auvinen K, Kreutzman A, Rousselot P, Hernesniemi S, Melo T, ... Porkka K.
    Leukemia. 2012
  36. Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications.
    Italiano A, Saada E, Cioffi A, Poulette S, Bouchet S, Molimard M, ... Bui B.
    Target Oncol. 2012
  37. One-year effectiveness of a 3-week balneotherapy program for the treatment of overweight or obesity.
    Hanh T, Serog P, Fauconnier J, Batailler P, Mercier F, Roques CF, Blin P.
    Evid Based Complement Alternat Med. 2012
  38. Les conflits d'intérêts dans le domaine des produits et de technologies de santé : état des lieux et recommandations.
    Demarez JP, Funck-Brentano C, Molimard M; participants à la table ronde N°4 de Giens XXVII.
    Therapie. 2012